CLINICAL_TRIALS
trial_result
· 2014-04-25
Clinical Trial Update: A Placebo-Controlled Study for SPM 962 in Restless Legs Syndrome (RLS) Patients [Phase 2]
Summary
A placebo-controlled Phase 2 study evaluating SPM 962 in adults with restless legs syndrome has completed and posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Otsuka Pharmaceutical Co., Ltd. | Conditions: Idiopathic Restless Legs Syndrome | Phase 2 | Status: COMPLETED | Results posted: 2014-04-25